Trademarkia Logo

Australia

AU$
FOPAL
Registered: Registered/protected

Last updated on 15 May 2023

Owner Info

Clementia Pharmaceuticals Inc., a corporation of Canada

1000 de la Gauchetière Street West

Suite 1200, Montreal, Quebec, H3B 4W5 CANADA

Serial Number

2311133 filed on 28 Oct 2022

Correspondent

Minter Ellison Rudd Watts

c/- Minter Ellison,

Collins Arch,

Melbourne, VIC, 3000 AUSTRALIA

FOPAL

Classification Information


Class [035]
Maintaining a registry of patient data and medical information relating to Fibrodysplasia ossificans progressiva (FOP) disease and treatment; conducti Read More

Class [042]
Providing a website featuring educational information in the fields of pharmaceuticals and clinical trials; providing medical and scientific research Read More

Class [044]
Providing an online computer database featuring a registry of medical information and patient records; medical information relating to Fibrodysplasia Read More

Mark Details


Serial Number

2311133

Registered On

28 Oct 2022

Renewal On

28 Oct 2032

Mark Type

WORD

Priority Claim (Convention Details)


Date

6 Oct 2022

Mark Type

CA

Legal History


Show more

Status DateAction Taken
15th May 2023IP Right Registered correspondence sent
15th May 2023IP Right Registration Published
15th May 2023Status change to Registered/Protected
7th Mar 2023Application Accepted correspondence sent
7th Mar 2023IP Right has been Examined
7th Mar 2023IP Right Acceptance Published
7th Nov 2022Early Acceptance Notice correspondence sent
7th Nov 2022Status change to Accepted
2th Nov 2022Awaiting examination
2th Nov 2022Examination expedited